Showing results (131-140 of 829) with videos related to
Sort By:
Pageof 83
BMJ Open Diabetes Research & Care|May 26, 2026
Mapping shared genetic determinants of eGFR and albuminuria with a focus on type 2 diabetes: a large-scale European studyCilia Naaman, Frederik Persson, Thomas Kümler, et al.Diabetes, Obesity & Metabolism|October 19, 2016
The effect of liraglutide on renal function: A randomized clinical trialBernt J von Scholten, Frederik Persson, Signe Rosenlund, et al.Journal of Diabetes and Its Complications|August 14, 2022
Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetesHenrik Ø Hjortkjær, Frederik Persson, Simone Theilade, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 17, 2018
Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetesSascha Pilemann-Lyberg, Tine Willum Hansen, Frederik Persson, et al.Diabetes, Obesity & Metabolism|February 3, 2022
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrologySimke W Waijer, Michele Provenzano, Skander Mulder, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 14, 2003
Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion ratePeter Gaede, Henrik Post Hansen, Hans-Henrik Parving, et al.Journal of the American Society of Nephrology : JASN|March 28, 2003
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathyPeter Jacobsen, Steen Andersen, Berit R Jensen, et al.The New England Journal of Medicine|February 8, 2008
Effect of a multifactorial intervention on mortality in type 2 diabetesPeter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, et al.Diabetes, Obesity & Metabolism|September 18, 2023
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled studySuvanjaa Sivalingam, Victor Soendergaard Wasehuus, Viktor Rotbain Curovic, et al.Plos One|July 30, 2021
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetesElisabeth Buur Stougaard, Signe Abitz Winther, Hanan Amadid, et al.Pageof 83